The Endocrine System
Slide deck, chapter 2135 slidesChapter outline and sourcesPractice questions
-
21.1 Hormone classes predict storage, transport and half-life
- Peptides and proteins are made as preprohormones, cut in the ER and Golgi, stored in granules and released by Ca2+-triggered exocytosis; they travel free, so half-lives are short.
- Steroids derive from cholesterol, are not stored but made on demand, and ride on carrier proteins, which lengthens half-life well beyond that of peptides.
- Amines split in two: catecholamines are hydrophilic and stored in granules; thyroid hormones are lipophilic, heavily protein bound and long lived.
- Eicosanoids are made from membrane arachidonic acid and act locally as paracrine or autocrine signals, so they never reach a plasma pool of note.
- Rule of thumb: water-soluble hormones bind surface receptors; lipid-soluble hormones cross the membrane and need carriers in plasma.
Outcome
- 1Classify hormones as peptide/protein, steroid, amine (catecholamine or thyroid) or eicosanoid and predict storage, transport and half-life from the class.
-
21.1 Membrane receptor cascades with a named hormone each
- Gs raises adenylyl cyclase, cAMP and protein kinase A (ACTH, glucagon, TSH, PTH); Gi lowers cAMP (somatostatin).
- Gq activates phospholipase C to make IP3, which frees Ca2+ from the ER, and DAG, which activates protein kinase C (TRH, GnRH, oxytocin).
- Receptor tyrosine kinases (insulin, IGF-1) autophosphorylate and recruit IRS proteins, feeding PI3K-Akt and Ras-MAPK.
- Cytokine receptors (GH, prolactin, leptin) lack kinase activity and recruit JAK2, which phosphorylates STAT dimers that enter the nucleus.
- Guanylyl cyclase receptors raise cGMP (ANP, BNP); each step amplifies the signal and phosphodiesterases and phosphatases end it.
Outcome
- 2Compare the signalling cascades of Gs, Gi, Gq, receptor tyrosine kinase, cytokine (JAK-STAT) and guanylyl cyclase receptors with a named hormone for each.
-
21.1 Nuclear receptors and why they act slowly
- Steroid receptors (glucocorticoid, mineralocorticoid, sex steroids) wait in the cytoplasm bound to heat-shock proteins until ligand arrives, then dimerize and enter the nucleus.
- Thyroid hormone, vitamin D and retinoid receptors already sit in the nucleus and pair with RXR before binding response elements.
- The ligand-receptor complex binds hormone response elements and recruits co-activators or co-repressors to change transcription.
- The effect needs new mRNA and protein, so onset takes hours, whereas second-messenger signalling at the membrane acts in seconds to minutes.
Outcome
- 3Explain how nuclear receptors for steroid, thyroid, vitamin D and retinoid hormones alter gene transcription and why the onset is slower than for membrane receptors.
-
21.1 Binding proteins, clearance and free hormone
- Only free hormone is active; bound hormone is a reservoir that cannot cross capillaries until it dissociates.
- Cortisol is 90 to 95 percent bound, mainly to CBG, giving a half-life of 60 to 90 minutes; aldosterone is only about 60 percent bound and lasts about 20 minutes.
- More than 99 percent of thyroid hormone is bound, so its half-life is long and a change in TBG moves total hormone without moving free hormone.
- Clearance is by receptor-mediated internalization, enzymatic degradation, hepatic conjugation and renal excretion.
- Read a total hormone level only alongside the binding protein state and the matching feedback hormone.
Outcome
- 4Describe how binding proteins, clearance and metabolism set free-hormone concentration and plasma half-life.
-
21.1 Feedback loops and secretion patterns
- Negative feedback is the rule: cortisol suppresses CRH and ACTH. Positive feedback is rare, as in oxytocin during labor.
- Long loops are target hormone acting on pituitary or hypothalamus, short loops are pituitary hormone acting on hypothalamus, ultrashort loops are local effects on the releasing cell.
- Pulsatile secretion (GnRH, GH) carries information in its rhythm; circadian secretion (cortisol peaking near waking) follows the day.
- Stimulus-driven secretion, such as insulin after glucose, follows the level of the regulated variable.
Outcome
- 5Distinguish negative feedback, positive feedback, long/short/ultrashort loops and pulsatile versus circadian secretion with one example each.
-
21.1 Receptor regulation and hormone interactions
- Sustained high ligand lowers receptor number or sensitivity (down-regulation, desensitization), as with insulin receptors in obesity.
- Continuous rather than pulsatile GnRH desensitizes gonadotrophs, which is why GnRH agonists suppress the gonadal axis.
- Permissive interactions need one hormone to allow another to act (cortisol allows catecholamine vascular tone).
- Synergism adds effects beyond the sum (GH plus cortisol raising glucose); antagonism opposes them (insulin versus glucagon).
Outcome
- 6Explain receptor up- and down-regulation, desensitization and permissive, synergistic and antagonistic hormone interactions.
-
21.2 Pituitary origin, parts and portal blood supply
- The adenohypophysis comes from Rathke pouch, an upgrowth of oral ectoderm; the neurohypophysis is a downgrowth of diencephalic neuroectoderm.
- Adenohypophysis parts are pars distalis, pars tuberalis and pars intermedia; neurohypophysis parts are pars nervosa, infundibulum and median eminence.
- Superior hypophyseal arteries feed a primary capillary plexus in the median eminence; portal veins carry releasing hormones to a secondary plexus in the pars distalis.
- Inferior hypophyseal arteries supply the pars nervosa. The gland sits in the sella turcica below the optic chiasm, so a mass gives bitemporal hemianopsia.
Outcome
- 7Describe the embryologic origin, parts and blood supply of the pituitary, including the hypophyseal portal system.
-
21.2 Hypothalamic releasing and inhibiting hormones
- TRH acts on thyrotrophs (TSH, and prolactin); CRH on corticotrophs (POMC to ACTH); GnRH on gonadotrophs (LH, FSH); GHRH on somatotrophs (GH).
- Dopamine inhibits prolactin; somatostatin inhibits GH and TSH.
- Parvocellular neurons release into the portal system, and GnRH must arrive in pulses (about hourly) for gonadotrophs to respond.
- Prolactin is the one anterior hormone under tonic inhibition, so a stalk lesion raises prolactin and lowers the others.
- POMC is also cleaved to beta-lipotropin and MSH peptides, which is why excess ACTH darkens skin.
Outcome
- 8Name each hypothalamic releasing and inhibiting hormone with its anterior pituitary target cell and product.
-
21.2 Growth hormone, IGF-1 and its disorders
- GH acts through JAK2-STAT5, mainly in liver, to make IGF-1; IGF-1 feeds back and stimulates somatostatin.
- Metabolic effects: lipolysis, reduced glucose uptake (anti-insulin), protein anabolism, and growth of cartilage at epiphyseal plates.
- Secretion is pulsatile with peaks in deep sleep; hypoglycemia, exercise, ghrelin and stress raise it; hyperglycemia and IGF-1 lower it.
- Excess before plate closure gives gigantism; after closure it gives acromegaly with acral growth, prognathism, glucose intolerance and headache.
- Childhood deficiency gives proportionate short stature; Laron dwarfism is GH-receptor resistance with high GH and low IGF-1.
Outcome
- 9Explain growth hormone secretion, IGF-1 mediation and metabolic actions, and predict acromegaly and pituitary dwarfism.
-
21.2 ADH and oxytocin from the posterior pituitary
- Both nonapeptides are made in supraoptic and paraventricular nuclei, travel with neurophysin down the hypothalamo-hypophyseal tract and are released from axon terminals in the pars nervosa.
- ADH is suppressed below a plasma osmolality of about 280 mOsm/kg and rises above it (a 1 percent change is enough); blood volume must fall about 10 percent before ADH rises appreciably.
- V2 receptors insert aquaporin-2 in collecting-duct principal cells; V1 receptors constrict vessels.
- Central diabetes insipidus lacks ADH; nephrogenic lacks the response. Desmopressin corrects the first only. SIADH gives euvolemic hyponatremia with concentrated urine.
- Oxytocin acts through Gq on myometrium (the Ferguson reflex, positive feedback in labor) and on myoepithelial cells for milk let-down.
Outcome
- 10Explain the synthesis, transport and release of ADH and oxytocin from the posterior pituitary and the stimuli that control each.
-
21.2 Stimulation and suppression test logic
- Read the target-gland hormone with the pituitary hormone: low T4 with high TSH is primary failure, low T4 with low TSH is central.
- Stimulation tests prove deficiency by failing to raise the hormone (insulin tolerance or glucagon for GH and ACTH, cosyntropin for adrenal reserve).
- Suppression tests prove autonomy by failing to lower it: an oral glucose load fails to suppress GH in acromegaly.
- Low-dose dexamethasone should suppress ACTH and cortisol; failure supports Cushing syndrome, and high-dose suppression separates a pituitary source from an ectopic one.
Outcome
- 11Interpret stimulation and suppression test logic for pituitary axes, including a dexamethasone suppression and an oral glucose GH suppression.
-
21.2 Pituitary histology
- Pars distalis is cords of cells around sinusoids: acidophils (somatotrophs, lactotrophs) stain pink, basophils (corticotrophs, thyrotrophs, gonadotrophs) blue-purple, chromophobes faintly.
- Pars nervosa is pale and fibrous, with unmyelinated axons, pituicytes (glial support cells) and Herring bodies, which are swellings full of stored oxytocin or ADH.
- Pars intermedia can show colloid-filled cysts; pars tuberalis wraps the stalk.
Outcome
- 12Identify acidophils, basophils, chromophobes, Herring bodies and pituicytes on pituitary slides.
-
21.3 Thyroid relations, supply and development
- Two lobes joined by an isthmus over tracheal rings 2-3 sit anterior to the trachea, deep to sternothyroid and sternohyoid.
- The superior thyroid artery comes from the external carotid and the inferior thyroid artery from the thyrocervical trunk; a thyroid ima artery is an occasional variant.
- The recurrent laryngeal nerve runs near the inferior thyroid artery and the external branch of the superior laryngeal nerve near the superior artery, so both are at risk in thyroidectomy.
- The gland descends from the foramen cecum as the thyroglossal duct; persistence gives a thyroglossal cyst and a pyramidal lobe is a remnant.
Outcome
- 13Describe the gross relations, blood supply and embryologic origin of the thyroid, including the thyroglossal duct tract.
-
21.3 Thyroid histology and follicle height
- Follicles are lined by simple cuboidal follicular cells around colloid rich in thyroglobulin.
- Active follicles have tall columnar cells and scalloped, depleted colloid; resting follicles have flat cells and abundant colloid.
- Parafollicular C cells are pale cells between follicles or in the basal epithelium and make calcitonin.
- Fenestrated capillaries wrap the follicles and let hormone enter blood.
Outcome
- 14Identify follicles, colloid, follicular cells and parafollicular C cells on a thyroid slide and relate follicle height to activity.
-
21.3 Steps of thyroid hormone synthesis and their blockers
- The Na+/I- symporter traps iodide against its gradient; perchlorate and thiocyanate compete for it.
- Pendrin moves iodide into the lumen, where thyroid peroxidase oxidizes it and iodinates tyrosines of thyroglobulin to make MIT and DIT.
- TPO also couples DIT with DIT to form T4 and MIT with DIT to form T3; methimazole and PTU inhibit TPO.
- TSH drives colloid endocytosis, proteolysis and release of T4 and T3; excess iodide transiently blocks release (Wolff-Chaikoff effect).
- Output is mainly T4 at about 14 to 1 (roughly 93 percent T4, 7 percent T3), and the adult iodine RDA is 150 micrograms per day.
Outcome
- 15Sequence the steps of thyroid hormone synthesis from iodide trapping to secretion and name the enzyme and drug blocking each step.
-
21.3 T4 to T3, transport and actions
- More than 99 percent of thyroid hormone is bound, mainly to TBG; free hormone acts.
- T4 is a prohormone: deiodinases 1 and 2 make active T3 in tissues (about four-fifths of circulating T3), while deiodinase 3 makes inactive reverse T3.
- T3 binds nuclear receptors paired with RXR; it raises Na+/K+-ATPase, basal metabolic rate, heat production, beta-receptor expression and cardiac output.
- It is required for growth and CNS development, so untreated congenital hypothyroidism causes cretinism.
- It raises glycolysis, gluconeogenesis, lipolysis and LDL receptor clearance, so hypothyroidism raises LDL.
Outcome
- 16Explain peripheral T4-to-T3 conversion, transport proteins and the mechanism and metabolic effects of thyroid hormone.
-
21.3 Thyroid laboratory patterns
- Primary hypothyroidism: low free T4 with high TSH. Central hypothyroidism: low free T4 with low or inappropriately normal TSH.
- Primary hyperthyroidism: high free T4 with suppressed TSH. A TSH-secreting source gives high T4 with non-suppressed TSH.
- Graves disease: antibodies mimic TSH, causing a diffuse goiter, exophthalmos and low TSH.
- Hashimoto thyroiditis: anti-TPO and antithyroglobulin antibodies with lymphocytic infiltrate, ending in hypothyroidism with high TSH.
- Iodine deficiency lowers hormone output, TSH stays high and a goiter forms.
Outcome
- 17Predict laboratory patterns (TSH, free T4) in primary and central hypo- and hyperthyroidism and in Graves and Hashimoto disease.
-
21.4 Parathyroid location, supply and histology
- Usually four glands lie on the posterior thyroid surface, separated from it by a connective tissue capsule; the superior pair come from pouch IV and the inferior pair from pouch III.
- Pouch III also forms the thymus, so inferior glands can descend ectopically into the mediastinum.
- Blood comes mainly from the inferior thyroid artery, so thyroidectomy can devascularize them.
- Chief cells are small, dark-staining and secrete PTH; oxyphil cells are larger, eosinophilic, mitochondria rich and function unclear; adipocytes increase with age.
Outcome
- 18Locate the four parathyroid glands and their blood supply and identify chief and oxyphil cells on a slide.
-
21.4 Calcium-sensing receptor control of PTH
- The calcium-sensing receptor on chief cells is a Gq receptor that is activated by high Ca2+.
- Falling Ca2+ takes the brake off, so PTH rises within minutes; rising Ca2+ suppresses it, closing a negative feedback loop.
- Severe magnesium deficiency also impairs PTH release.
- Total serum calcium is about 9 to 10.5 mg/dL and ionized about 4.7 to 5.2 mg/dL, so a small fall in ionized Ca2+ is a strong secretory signal.
Outcome
- 19Explain the regulation of PTH secretion by extracellular Ca2+ through the calcium-sensing receptor.
-
21.4 PTH actions on bone, kidney and gut
- Bone: PTH acts on osteoblasts, which express RANKL and activate osteoclasts, releasing Ca2+ and phosphate; sustained PTH is catabolic, intermittent dosing is anabolic.
- Kidney: more Ca2+ reabsorption in the distal tubule, less phosphate reabsorption in the proximal tubule, and stimulation of 1-alpha-hydroxylase.
- Gut: the effect is indirect, through calcitriol made in the kidney.
- Net result: serum Ca2+ rises and phosphate falls; PTH acts through Gs and cAMP.
Outcome
- 20Describe PTH actions on bone, kidney and, indirectly, intestine.
-
21.4 Vitamin D activation and actions
- UVB converts 7-dehydrocholesterol in skin to cholecalciferol; diet adds D2 and D3.
- The liver 25-hydroxylates to calcidiol, the storage form measured clinically; the kidney 1-alpha-hydroxylates to calcitriol, the active hormone.
- Renal 1-alpha-hydroxylase is stimulated by PTH, low phosphate and low Ca2+.
- Calcitriol raises intestinal Ca2+ and phosphate absorption, supports bone mineralization and suppresses PTH.
- Deficiency causes rickets in children and osteomalacia in adults.
Outcome
- 21Trace vitamin D from skin or diet through hepatic 25-hydroxylation and renal 1-alpha-hydroxylation to calcitriol and describe its actions.
-
21.4 Integrating calcium control and hyperparathyroidism
- Hypocalcemia raises PTH and calcitriol and gives tetany (Chvostek and Trousseau signs); hypercalcemia raises calcitonin from C cells, a minor adult role.
- FGF23 from osteocytes increases phosphate excretion and suppresses 1-alpha-hydroxylase.
- Plasma calcium is about 50 percent ionized, about 40 percent protein bound and about 10 percent complexed; acidosis frees calcium from protein and alkalosis binds more.
- Primary hyperparathyroidism (adenoma): high Ca2+, low phosphate, high PTH. Secondary (renal failure): low Ca2+, high phosphate, high PTH.
- Chvostek sign (facial twitch on tapping the facial nerve) occurs in most acute hypocalcemia but also in up to 10 percent of healthy people; Trousseau sign is carpal spasm after 3 minutes of cuff use.
Outcome
- 22Integrate PTH, calcitriol, calcitonin and FGF23 into a response to hypo- and hypercalcemia and interpret primary and secondary hyperparathyroidism.
-
21.5 Adrenal zones and what each secretes
- Cortex from outside in: zona glomerulosa (rounded clusters, aldosterone), zona fasciculata (long cords of lipid-rich cells, cortisol), zona reticularis (anastomosing cords, DHEA and androgens).
- The medulla is made of chromaffin cells and secretes mainly epinephrine.
- Salt, sugar, sex: the order from outside inward matches mineralocorticoid, glucocorticoid, androgen.
- Each gland drains by one vein, right into the IVC and left into the left renal vein; preganglionic sympathetic fibers directly innervate the medulla.
Outcome
- 23Identify the three cortical zones and the medulla on an adrenal slide and give the principal hormone of each.
-
21.5 Steroidogenesis at overview level
- StAR carries cholesterol into mitochondria, the rate-limiting step, and CYP11A1 cleaves it to pregnenolone.
- Glomerulosa lacks 17-alpha-hydroxylase and has aldosterone synthase; fasciculata has 17-alpha-hydroxylase, 21-hydroxylase and 11-beta-hydroxylase for cortisol.
- Reticularis makes DHEA and androstenedione through 17,20-lyase; peripheral tissues convert them to testosterone and estrogens.
- 21-Hydroxylase deficiency blocks cortisol and aldosterone, ACTH rises, and steroid precursors are shunted to androgens.
- Renal 11-beta-HSD2 inactivates cortisol, protecting the mineralocorticoid receptor.
Outcome
- 24Outline steroidogenesis from cholesterol to aldosterone, cortisol and androgens, naming zone-specific enzymes at overview level.
-
21.5 Aldosterone regulation and action
- Angiotensin II (AT1, Gq) and hyperkalemia stimulate aldosterone release from glomerulosa; ACTH acts weakly; ANP inhibits it.
- In principal cells of the late distal tubule and collecting duct it raises ENaC and Na+/K+-ATPase activity and K+ secretion.
- Intercalated cells secrete H+, so excess aldosterone gives alkalosis.
- Excess (Conn syndrome): hypertension, hypokalemia, metabolic alkalosis and low renin. Deficiency: hypotension, hyponatremia and hyperkalemia.
Outcome
- 25Explain regulation of aldosterone by the renin-angiotensin system and potassium, and its effects on the collecting duct.
-
21.5 HPA axis and the actions of cortisol
- CRH drives ACTH drives cortisol; cortisol inhibits both CRH and ACTH. Secretion peaks near waking and is lowest at night.
- Metabolic actions: gluconeogenesis, protein catabolism, lipolysis with central fat redistribution and insulin resistance.
- Anti-inflammatory actions include inhibition of phospholipase A2 through lipocortin and fewer cytokines, lymphocytes and eosinophils, with higher neutrophil counts.
- It is permissive for catecholamine vascular tone, and fetal cortisol promotes surfactant and organ maturation.
Outcome
- 26Explain the HPA axis, circadian rhythm and the metabolic, anti-inflammatory and permissive actions of cortisol.
-
21.5 Catecholamine synthesis, release and receptors
- Tyrosine goes to L-DOPA (tyrosine hydroxylase, rate-limiting), to dopamine, to norepinephrine, then to epinephrine by PNMT, which cortisol from cortical blood induces.
- Preganglionic sympathetic ACh acts on nicotinic receptors to trigger release, which is about 80 percent epinephrine and 20 percent norepinephrine.
- Alpha-1 vasoconstricts; beta-1 raises heart rate and contractility; beta-2 relaxes bronchi and muscle vessels and drives glycogenolysis and lipolysis.
- MAO and COMT break them down to metanephrines and VMA, the basis of pheochromocytoma testing.
Outcome
- 27Describe catecholamine synthesis, adrenal medullary release and receptor-specific effects of epinephrine.
-
21.5 Adrenal disorders mapped to pathways
- Cushing syndrome: cortisol excess with central obesity, striae, proximal weakness, hypertension, hyperglycemia; exogenous steroids are the commonest cause, Cushing disease is a pituitary ACTH source.
- Addison disease: autoimmune destruction with low cortisol and aldosterone, high ACTH and hyperpigmentation, hypotension, hyponatremia and hyperkalemia.
- 21-Hydroxylase CAH: low cortisol, high ACTH, high 17-OH-progesterone and androgen excess.
- Conn syndrome: aldosterone excess with low renin and low K+. Pheochromocytoma: episodic hypertension, headache, sweating and palpitations with raised metanephrines.
Outcome
- 28Relate Cushing syndrome, Addison disease, congenital adrenal hyperplasia, Conn syndrome and pheochromocytoma to the pathways they disturb.
-
21.5 Alarm, resistance and exhaustion
- Alarm (fight-or-flight): sympathetic activity and medullary catecholamines raise heart rate, blood glucose and flow to muscle.
- Resistance: sustained cortisol, GH, glucagon, ADH and aldosterone defend glucose and fluid volume.
- Exhaustion: depleted reserves and prolonged cortisol exposure bring immunosuppression, hypertension, hyperglycemia and mood disturbance.
Outcome
- 29Sequence the alarm, resistance and exhaustion phases of the stress response.
-
21.6 Islet cell types and positions
- Islets are pale clusters among darker exocrine acini on H&E, with dense fenestrated capillaries.
- Beta cells are the majority of islet cells (roughly 60 to 75 percent depending on the study) and make insulin and amylin; they sit toward the center of the islet.
- Alpha cells (roughly 20 to 30 percent) make glucagon and lie toward the periphery; delta cells, a few percent, make somatostatin.
- PP (F) cells, about 1 percent, make pancreatic polypeptide; islets are only 1 to 2 percent of pancreatic mass yet number in the millions.
Outcome
- 30Identify alpha, beta and delta cells in an islet and give the hormone and location (islet center or periphery) of each.
-
21.6 Insulin synthesis and glucose-stimulated release
- Preproinsulin becomes proinsulin in the ER; the Golgi cleaves it to insulin plus C-peptide in equal amounts, so C-peptide marks endogenous secretion.
- Glucose enters beta cells through GLUT2, and glucokinase sets the sensing rate; ATP rises and closes K-ATP channels.
- Depolarization opens voltage-gated Ca2+ channels, and Ca2+ triggers granule exocytosis.
- Sulfonylureas close K-ATP channels directly; GLP-1 and GIP amplify release through cAMP; secretion is biphasic.
Outcome
- 31Describe insulin synthesis from preproinsulin to proinsulin and C-peptide and the glucose-stimulated pathway of release.
-
21.6 Insulin receptor signalling and target tissues
- The tyrosine kinase receptor phosphorylates IRS proteins, activating PI3K-Akt (metabolic) and Ras-MAPK (mitogenic) arms.
- Muscle and fat: GLUT4 translocation, glycogen and protein synthesis, lipogenesis and inhibition of hormone-sensitive lipase.
- Liver glucose uptake is GLUT2 and insulin independent; insulin raises glycogen synthesis and lipogenesis and suppresses gluconeogenesis and ketogenesis.
- Insulin also drives K+ into cells through Na+/K+-ATPase, which treats hyperkalemia; its half-life is about 4 to 6 minutes.
Outcome
- 32Explain insulin receptor signalling and the effects on liver, muscle and adipose tissue, including GLUT4 recruitment.
-
21.6 Glucagon and counter-regulation
- Glucagon acts through Gs-cAMP-PKA in liver: glycogenolysis, gluconeogenesis and ketogenesis, with little effect on muscle.
- Release rises with hypoglycemia, amino acids and sympathetic input; insulin and somatostatin suppress it.
- In hypoglycemia insulin falls first, glucagon and epinephrine rise next, and cortisol and GH act over hours.
Outcome
- 33Explain glucagon actions and the counter-regulatory response to hypoglycemia.
-
21.6 Type 1, type 2 diabetes and ketoacidosis
- Type 1: autoimmune beta-cell destruction (anti-GAD, islet-cell antibodies), absolute insulin deficiency and ketosis.
- Type 2: insulin resistance with relative deficiency; plasma insulin may be several-fold above normal; ketoacidosis is rare but a hyperosmolar state occurs.
- Diabetic ketoacidosis: hyperglycemia, ketonemia, anion-gap acidosis, osmotic diuresis and total body K+ depletion even if serum K+ is normal or high.
- Chronic complications come from glycation and polyol injury: retinopathy, nephropathy, neuropathy and macrovascular disease.
- Diagnosis: fasting glucose 126 mg/dL or more or A1C 6.5 percent or more (random or 2-hour OGTT glucose 200 or more); prediabetes is fasting 100-125 mg/dL or A1C 5.7-6.4 percent.
Outcome
- 34Compare type 1 diabetes, type 2 diabetes and diabetic ketoacidosis in mechanism, laboratory findings and acute and chronic complications.
-
21.6 Hormones of other endocrine tissues
- Pineal melatonin is made from serotonin and released at night; light via the suprachiasmatic nucleus inhibits it.
- Gonads make testosterone and inhibin (testis) and estrogen, progesterone and inhibin (ovary); the placenta makes hCG, progesterone, estrogen and placental lactogen.
- Gut: gastrin, secretin, CCK, GIP, GLP-1 and ghrelin. Kidney: erythropoietin, calcitriol and renin.
- Heart: ANP and BNP. Adipose: leptin and adiponectin. Thymus: thymosin.
Outcome
- 35Summarize the hormones of the pineal, gonads, placenta, gut, kidney, heart and adipose tissue and their stimuli.